{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:17:01Z","timestamp":1776377821448,"version":"3.51.2"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.pcd.2015.08.001","type":"journal-article","created":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T12:40:26Z","timestamp":1440852026000},"page":"142-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Predictors of early discontinuation of basal insulin therapy in type 2 diabetes in primary care"],"prefix":"10.1016","volume":"10","author":[{"given":"K.","family":"Kostev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.W.","family":"Dippel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Rathmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2015.08.001_bib0130","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-012-2534-0","article-title":"Management of hyperglycaemia in type 2 diabetes: a patient-centered approach, position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"55","author":"Inzucchi","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.pcd.2015.08.001_bib0135","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2337\/diacare.27.5.1218","article-title":"A systematic review of adherence with medications for diabetes","volume":"27","author":"Cramer","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2015.08.001_bib0140","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s12325-014-0120-1","article-title":"Much ado about nothing? A real-world study of patients with type 2 diabetes switching basal insulin analogs","volume":"31","author":"Wei","year":"2014","journal-title":"Adv. Ther."},{"issue":"4","key":"10.1016\/j.pcd.2015.08.001_bib0145","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002348","article-title":"Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database study","volume":"3","author":"Wang","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.pcd.2015.08.001_bib0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5414\/CP201572","article-title":"Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in type-2 diabetic patients: comparison of insulin glargine with NPH insulin","volume":"50","author":"Quinzler","year":"2012","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pcd.2015.08.001_bib0155","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1055\/s-0028-1098896","article-title":"Higher persistence with basal supported oral therapy (BOT) with insulin glargine compared to NPH insulin therapy combined with oral antidiabetics","volume":"4","author":"Pfohl","year":"2009","journal-title":"Diabetologie"},{"key":"10.1016\/j.pcd.2015.08.001_bib0160","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.ehrm.2011.02.001","article-title":"Basal supported oral therapy with insulin glargine results in longer persistence and lower costs compared with insulin detemir in type 2 diabetics in Germany","volume":"2","author":"Pfohl","year":"2011","journal-title":"Health Outcome Res. Med."},{"key":"10.1016\/j.pcd.2015.08.001_bib0165","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.pcd.2015.01.011","article-title":"Treatment persistence after initiating basal insulin in type 2 diabetes patients: a primary care database analysis","volume":"9","author":"Pscherer","year":"2015","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.pcd.2015.08.001_bib0170","doi-asserted-by":"crossref","first-page":"617","DOI":"10.5414\/CPP47617","article-title":"Validity and representativeness of the disease analyzer patient database for use in pharmacoepidemiological and pharmacoeconomic studies","volume":"47","author":"Becher","year":"2009","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pcd.2015.08.001_bib0175","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining co-morbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med. Care"},{"key":"10.1016\/j.pcd.2015.08.001_bib0180","first-page":"54","article-title":"Good practice of secondary data analysis, first revision","volume":"70","author":"Swart","year":"2008","journal-title":"Gesundheitswesen"},{"key":"10.1016\/j.pcd.2015.08.001_bib0185","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1464-5491.2007.02341.x","article-title":"Hypoglycaemia in type 2 diabetes","volume":"25","author":"Amiel","year":"2008","journal-title":"Diabet. Med."},{"key":"10.1016\/j.pcd.2015.08.001_bib0190","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2337\/diaspect.15.1.20","article-title":"Negotiating the barrier of hypoglycemia in diabetes","volume":"15","author":"Cryer","year":"2002","journal-title":"Diabetes Spectr."},{"issue":"9 Suppl. 1","key":"10.1016\/j.pcd.2015.08.001_bib0195","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.amjmed.2013.06.012","article-title":"Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetes","volume":"126","author":"Ross","year":"2013","journal-title":"Am. J. Med."},{"key":"10.1016\/j.pcd.2015.08.001_bib0200","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1370\/afm.1501","article-title":"Association of depression with increased risk of severe hypoglycemic episodes in patients with diabetes","volume":"11","author":"Katon","year":"2013","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.pcd.2015.08.001_bib0205","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pcd.2013.10.001","article-title":"Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: a retrospective database analysis","volume":"8","author":"Kostev","year":"2014","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.pcd.2015.08.001_bib0210","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1464-5491.2005.01414.x","article-title":"Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors","volume":"22","author":"Hermanns","year":"2005","journal-title":"Diabet. Med."},{"key":"10.1016\/j.pcd.2015.08.001_bib0215","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.2337\/diacare.27.9.2154","article-title":"Relationship of depression and diabetes self-care, medication adherence, and preventive care","volume":"27","author":"Lin","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2015.08.001_bib0220","doi-asserted-by":"crossref","first-page":"950","DOI":"10.2337\/diacare.28.4.950","article-title":"Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes","volume":"28","author":"Rosenstock","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2015.08.001_bib0225","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.clinthera.2007.08.020","article-title":"Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycaemia outcomes across eleven phase III and IV studies of insulin glargine compared with neutral protamin Hagedorn insulin in type 1 and type 2 diabetes mellitus","volume":"29","author":"Mullins","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.pcd.2015.08.001_bib0230","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jdiacomp.2014.04.003","article-title":"Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: evidence from a long-term controlled trial","volume":"28","author":"Rosenstock","year":"2014","journal-title":"J. Diabet. Complications"},{"key":"10.1016\/j.pcd.2015.08.001_bib0235","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1463-1326.2010.01232.x","article-title":"Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine","volume":"12","author":"Home","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.pcd.2015.08.001_bib0240","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/S0140-6736(98)12459-5","article-title":"Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens","volume":"354","author":"Jehle","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pcd.2015.08.001_bib0245","first-page":"1","article-title":"Different injection frequencies of basal insulins in type 2 diabetes patients under real-life conditions: a retrospective database analysis","volume":"5","author":"Rathmann","year":"2013","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.pcd.2015.08.001_bib0250","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1055\/s-0029-1208087","article-title":"Quality of life and treatment satisfaction in patients being treated with long acting insulin analogues: systematic review","volume":"134","author":"Hagenmeyer","year":"2009","journal-title":"Dtsch Med Wochenschr"}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991815001047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991815001047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:55:43Z","timestamp":1761695743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991815001047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1751991815001047"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2015.08.001","relation":{},"ISSN":["1751-9918"],"issn-type":[{"value":"1751-9918","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of early discontinuation of basal insulin therapy in type 2 diabetes in primary care","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2015.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}